Post Center Clinical Laboratory

Summary Statement of Deficiencies D0000 A recertification survey was conducted on March 13, 2026, Inmediate Jeopardy exist for the following conditions : D5002-42 C.F.R 493.1201 Condition : Bacteriology D6076-42 C.F.R 493.1441 Condition : Laboratory Director, high complexity. D3039 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(5) (a)(5) Quality system assessment records. Retain all laboratory quality system assessment records for at least 2 years. This STANDARD is not met as evidenced by: Based on lack of Quality Assessment (QA) records and laboratory general supervisor interview on March 13, 2026 at 1:20 p.m., that the laboratory did not perform the evaluations of the Quality Assessment Program in order to monitor and evaluate the laboratory activities (general system, pre-analytic, analytic and post-analytic systems) since December 2024. The findings include: 1. The laboratory did not evaluate the established Quality Assessment program since December 2024. 2. The laboratory general supervisor confirmed on March 13, 2026 at 1:20 p.m., that the laboratory did not evaluate nor document the established Quality Assessment program in the laboratory since December 2024. D5002 BACTERIOLOGY CFR(s): 493.1201 If the laboratory provides services in the subspecialty of Bacteriology, the laboratory must meet the requirements specified in 493.1230 through 493.1256, 493.1261, and 493.1281 through 493.1299. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 8 -- This CONDITION is not met as evidenced by: Based on Bacteriology quality control records review ( year 2025-2026 ) and lack of bacteriology quality control on March 13, 2026 at 1:15 p.m.the laboratory failed to be in compliance with the bacteriology analytic system requirements . Refer to D5401, D5403, D5413, D5429 and D5441. D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on personnel competence records review (years 2024-2026) and laboratory supervisor interview on March 13, 2026 at 10: 25 AM, the laboratory failed to follow the established schedule for competency evaluation for the technical supervisor, general supervisor, technical consultant, clinical consultant and medical technologist. The finding includes: 1. On March 13, 2026 at 10: 25 AM, the laboratory written policies for personnel competency procedures showed that the competency procedures must be performed annually. 2. The laboratory technical supervisor was designated as general supervisor, technical consultant, and medical technologist. The competence records showed that the laboratory did not evaluate the personnel competency since December 2024. 3. The clinical consultant competency was not evaluated since December 2024. 4. During the interview on March 13, 2026 at 10: 25 AM, the laboratory supervisor confirmed that the technical supervisor, general supervisor, technical consultant, medical technologist and clinical consultant competency evaluation were not performed. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on Quality Assessment (QA) activities, bacteriology IQCP, QA work sheets records review ( year 2024-2025) and laboratory general supervisor interview on March 13, 2026 at 1:15 p.m. the laboratory failed to evaluate and monitor the General Laboratory system requirements. The findings include: 1. On March 13, 2026 at 1:15 p.m. the laboratory general system QA activities, since December 2024 , were requested. 2. The QA records showed that the laboratory failed to evaluate the following QA activities : a. patient confidentiality- since December 13, 2024. b. specimen identification - since November 6, 2024. c. specimen integrity- since December 13, 2024. d. communications - since 12/13/2024 e.personnel competence- since 12/17/2024 3. On March 13, 2026 at 1:00 p.m. QA activities related to the bacteriology IQCP were requested. The reviewed QA worksheets showed that the evaluation must be performed every month. The last evaluation was performed on August 2025. 4. The laboratory general supervisor confirmed on March 13, 2026 at 1: -- 2 of 8 -- 15 p.m. that the laboratory failed to monitor the general laboratory systems practices related to: patient confidentiality, specimen identification and integrity, personnel competence and communications since December 2024. D5391 PREANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1249(a) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems specified at 493.1241 through 493.1242. This STANDARD is not met as evidenced by: Based on Quality Assessment (QA) activities records review (year 2024-2025) and laboratory general supervisor interview on March 13, 2026 at 1:15 p.m. the laboratory failed to evaluate and monitor the pre analytic system requirements. The findings include: 1. The QA records showed that the laboratory failed to evaluate the following pre-analytic QA activities : medical order - since December 2, 2024. 2. The laboratory general supervisor confirmed on March 13, 2026 at 1:15 p.m.that the laboratory failed to monitor the medical order since December 2,2024. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) (a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on review on March 13, 2026 at 12:45 p.m. of the bacteriology IQCP and interview with the laboratory general supervisor, the laboratory did not follow written procedures established for the bacteriology IQCP. The findings include: 1. The IQCP written plan showed that the laboratory must review the implemented plan, each year. There were no review of the IQCP since the implementation date on March 2020. 2. Review of the quality control records showed that the laboratory did not follow the implemented culture media control plan and not the daily incubator temperature record . Refer to D5441. 3. During interview with the general supervisor,she acknowledge the deficient practices. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) (b) The procedure manual must include the following when applicable to the test procedure: (b)(1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (b)(2) Microscopic examination, including the detection of inadequately prepared slides. (b)(3) Step-by- step performance of the procedure, including test calculations and interpretation of results. (b)(4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (b)(5) Calibration and calibration verification procedures. (b)(6) The reportable range for test results for the test system as -- 3 of 8 -- established or verified in 493.1253. (b)(7) Control procedures. (b)(8)

Summary Statement of Deficiencies D2081 GENERAL IMMUNOLOGY CFR(s): 493.837(d) Failure to return proficiency testing results to the proficiency testing program within the time frame specified by the program is unsatisfactory performance and results in a score of 0 for the testing event. This STANDARD is not met as evidenced by: Based on Puerto Rico Proficiency Testing Program records review in 2016-2017 and laboratory general superviso interview on March 9, 2018 at 10:00 AM, it was determined that the laboratory failed to report the general immunology proficiency testing results withim the time frame established by the program. The findings include: 1. Proficiency testing records were reviewed from February 2016 to July 2017. 2. The deadline of the first testing event report of general immunology tests was May 2017. 3. The laboratory did not report the first testing event of general immunology within the time frame established by the Proficiency Testing Program and results in a score of 0 % for the testing event. 4. The laboratory general supervisorr confirmed on March 9, 2018 at 10:00 A.M. that the laboratory did not report the general immunology proficiency testing results of the first testing event within the time frame established by the Proficiency Testing Program. D2127 HEMATOLOGY CFR(s): 493.851(d) Failure to return proficiency testing results to the proficiency testing program within the time frame specified by the program is unsatisfactory performance and results in a score of 0 for the testing event. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- This STANDARD is not met as evidenced by: Based on Puerto Rico Proficiency Testing Program records reviewed ( 2016-2017) and laboratory general supervisor interview on March 9, 2018 at 10:00 A.M., it was determined that the laboratory failed to report the hematology proficiency testing results within the time frame established by the program. The findings include: 1. Proficiency testing records were reviewed from February 2016 to July 2017. 2. The return deadline of the second testing event report of hematology tests was July 29, 2016. 3. The laboratory did not report the second testing event of hematology within the time frame established by the Proficiency Testing Program and results in a score of 0 % for the testing event. 4. The laboratory general supervisor confirmed on March 9, 2018 at 10:00 A.M. that the laboratory did not report the hematology proficiency testing results of the second testing event within the time frame established by the Proficiency Testing Program. D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Establish or verify the criteria for acceptability of all control materials. (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control materials must be defined and available. (ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (iii) Statistical parameters for unassayed control materials must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on lack of hematology statistical parameters from August 1, 20117 to September 13 2017, review of patient data log for year 2017 and interview with the laboratory general supervisor on March 9, 2018 at 11:10 AM, it was found that the laboratory did not evaluate nor define the statistical values of the lot number of the commercial control material used by the Excell Drew 3 hematology instrument. The findings include: 1. The laboratory uses Excell Dree 3 for hematology patient's samples tests. 2. The laboratory did not have statistical data (Levy-Jennings, control value mean and limits) of the control materials used from August 1, 2017 to September 13, 2017. 3. The patient data log from August 1, 2017 to September 13, 2017, showed that the laboratory performed one hundred fifty (150) Complete Blood Count (CBC) patient's samples. 4. The laboratory processed and reported one hundred fifty (150) CBC's patient's samples those days. 5. The laboratory general supervisor confirmed on March 9, 2018 at 11:10 AM that the laboratory failed to evaluate, monitor and take remedial actions for the statistical data (Levy-Jennings) those days. D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The -- 2 of 4 -- laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: Based on quality assessment (QA) records review in 2016-2018 and laboratory general supervisor interview on March 9, 2018 at 11:10 AM, it was determined that the laboratory failed to follow the established Quality Assessment Program to monitor and evaluate the requirement for analytic systems. The finding includes: 1. The laboratory did not evaluate nor define the statistical values of the lot number of the commercial control material used by the Excell Drew 3 hematology instrument from August 1, 2017 to September 13, 2017. Refer to D5469. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(i) Ensure that the proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on Puerto Rico Proficiency testing records review in 2016-2017 and laboratory general supervisor interview on March 9, 2018 at 10:00 AM, it was determined that the laboratory failed to ensure that proficiency testing samples were tested as required under Subpart H requirements. Refer to D2081 and D2127. D6093 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality control programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on hematology quality control records review from January 2016 to March 8, 2018 and laboratory general supervisor interview at 11:10 AM on March 9, 2018, it was determined that laboratory director failed to ensure compliance with the requirements for analytic systems. Refer to D5469. D6094 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality assessment programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on Quality Assessment (QA) records review in 2016-2018 and laboratory -- 3 of 4 -- general supervisor interview at 11:10 AM on March 9, 2018, it was determined that laboratory director failed to ensure compliance with quality assessment (QA) requirements. Refer to D5791. D6144 GENERAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1463 The general supervisor is responsible for day-to-day supervision or oversight of the laboratory operation and personnel performing testing and reporting test results. This STANDARD is not met as evidenced by: Based on hematology quality control records review in 2016-2018 and laboratory general supervisor interview on March 9, 2018 at 11:10 AM, it was determined that the general supervisor failed to follow quality control procedures. The findings include: 1. The laboratory did not evaluate nor define the statistical values of the lot number of the commercial control material used by the Excell Drew 3 hematology instrument. Refer to D5469. 2. The laboratory failed to report the hematology proficiency testing results within the time frame established by the Puerto Rico proficiency program. Refer to D2127. 3. The laboratory failed to report the general immunology proficiency testing results within the time frame established by the Puerto Rico proficiency program. Refer to D2081. -- 4 of 4 --